Develop.
Access.
Innovate.
Pioneering the way life-changing medicines are developed
and accessed for patients around the world.
Recent news & updates:
NewsAuxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial
Press ReleaseIan Fraser appointed as Executive Vice President, Clinical Development
Press ReleaseAmylyx Pharmaceuticals Announces Launch of U.S. Expanded Access Program for AMX0035
NewsBionical Emas stands with Ukraine
Our expertise.
Our approach.
We provide a unique, combined approach to Clinical Development, Early Access Programs and Clinical Trial Supply. Our expert teams work seamlessly across our divisions, where they continuously use their experience and knowledge to plan, develop and execute projects to exceptionally high standards.
We build long-term, mutually beneficial partnerships. We listen carefully to what you tell us and share our insight to enhance results and deliver success. We are innovative but realistic in our recommendations, meeting your objectives while staying true to your culture.
News.
At Bionical Emas, we like to keep our clients up-to-date with relevant news and key market insight.
